VideaHealth is a technology company.
VideaHealth has raised $60.0M across 2 funding rounds.
VideaHealth has raised $60.0M in total across 2 funding rounds.
VideaHealth is an AI-powered dental diagnostics company that builds VideaAI, a comprehensive platform analyzing dental X-rays to detect over 30 conditions like cavities, gum disease, abscesses, and bone loss in real time.[1][2][3][5][6] It serves dental service organizations (DSOs), independent practices, and clinicians—used by 8 of the 10 largest North American DSOs and over 50,000 providers—solving problems of inconsistent diagnostics, workflow inefficiencies, insurance fraud, and missed treatment opportunities by enabling earlier detection, automated charting, treatment recommendations, and revenue optimization.[1][5][6][8] The platform's growth momentum is strong: commercial launch in 2022, partnerships like a joint venture with Henry Schein (Dentrix Detect AI), onboarding 20,000+ Heartland Dental providers processing 50 million X-rays with 95% engagement, and analyzing 500 million X-rays annually as of mid-2025.[1][3][6][8]
VideaHealth was founded in 2018 as an MIT spinout by CEO Florian Hillen, who recognized AI's potential to reinvent dental diagnostics for better overall health outcomes, linking oral diseases to issues like heart disease and diabetes.[1][7][9] Hillen, with a background in AI development, built the "AI factory"—a process for rapidly iterating AI models trained by top 5% clinicians—to ensure high accuracy before market entry.[3][9] Early traction came from FDA clearances for 30+ detections (largest in dental AI, covering patients aged 3+), a 2022 commercial launch targeting large DSOs, and a pivotal 2024 joint venture with Henry Schein One, integrating AI into Dentrix software for seamless workflows.[1][3][6]
VideaHealth rides the AI-in-healthcare wave, specifically dental AI amid rising DSO consolidation (handling 50%+ of U.S. practices) and demand for preventive care tied to systemic health.[1][7] Timing aligns with FDA's accelerating AI clearances, post-2022 commercial viability of models like those from its MIT roots, and market forces like labor shortages, insurance scrutiny, and 500 million+ annual U.S. X-rays needing efficiency.[3][6][8] It influences the ecosystem by standardizing diagnostics via distributor integrations (e.g., Henry Schein), enabling DSO scale, and shifting dentistry from reactive to preventive, potentially impacting 1 billion patients globally.[1][7]
VideaHealth is poised for explosive growth, expanding its AI factory to detect broader medical risks from dental scans while launching features like aligner/implant recommendations.[2][8] Trends like DSO dominance, AI regulatory tailwinds, and holistic health integration will propel adoption, with potential for international scaling and insurer partnerships. Its influence may evolve from diagnostics leader to full dental operations platform, redefining care standards and capturing untapped revenue in a $150B+ U.S. market—building on its mission to reach 1 billion patients.[7][8]
VideaHealth has raised $60.0M in total across 2 funding rounds.
VideaHealth's investors include Andreessen Horowitz, Lux Capital, Pillar VC, Sierra Ventures, Sonder Capital, Spark Capital, Threshold Ventures, VZVC.
VideaHealth has raised $60.0M across 2 funding rounds. Most recently, it raised $40.0M Series B in January 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2025 | $40.0M Series B | Andreessen Horowitz, Lux Capital, Pillar VC, Sierra Ventures, Sonder Capital, Spark Capital, Threshold Ventures, VZVC | |
| Mar 1, 2022 | $20.0M Series A | Andreessen Horowitz, Pillar VC, Sierra Ventures, Spark Capital, VZVC |